Obsidian Therapeutics
-
Malvern-based Galera Therapeutics to Be Acquired In Reverse Merger
Malvern-based Galera Therapeutics will be acquired by Obsidian Therapeutics in an all-stock reverse merger, writes John George for the Philadelphia Business Journal. The two companies have secured a $350 million private…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
